Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125029213 | 12502921 | 3 | F | 20151009 | 20160915 | 20160628 | 20160922 | EXP | UA-ROCHE-1644764 | ROCHE | 49.00 | YR | M | Y | 0.00000 | 20160922 | MD | UA | UA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125029213 | 12502921 | 1 | PS | Atezolizumab | ATEZOLIZUMAB | 1 | Intravenous (not otherwise specified) | RECEIVED MOST RECENT DOSE ON 08/OCT/2015 | 1149125 | 761034 | 1200 | MG | INFUSION | Q3W | |||||
125029213 | 12502921 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | RECEIVED MOST RECENT DOSE ON 08/OCT/2015 | 0 | 876 | MG | Q3W | |||||||
125029213 | 12502921 | 3 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | RECEIVED MOST RECENT DOSE ON 08/OCT/2015 | 0 | 354 | MG | Q3W | |||||||
125029213 | 12502921 | 4 | C | KETOROLAC | KETOROLACKETOROLAC TROMETHAMINE | 1 | Unknown | 0 | |||||||||||
125029213 | 12502921 | 5 | C | KETOROLAC | KETOROLACKETOROLAC TROMETHAMINE | 1 | 0 | ||||||||||||
125029213 | 12502921 | 6 | C | NALBUFIN | 2 | Unknown | 0 | ||||||||||||
125029213 | 12502921 | 7 | C | NALBUFIN | 2 | 0 | |||||||||||||
125029213 | 12502921 | 8 | C | NIMESULIDE | NIMESULIDE | 1 | Unknown | 0 | |||||||||||
125029213 | 12502921 | 9 | C | NIMESULIDE | NIMESULIDE | 1 | 0 | ||||||||||||
125029213 | 12502921 | 10 | C | ESSENTIALE (PHOSPHOLIPID) | 2 | Unknown | 0 | ||||||||||||
125029213 | 12502921 | 11 | C | ESSENTIALE (PHOSPHOLIPID) | 2 | 0 | |||||||||||||
125029213 | 12502921 | 12 | C | NOVOCAINE | PROCAINE | 1 | Unknown | INDICATION: ANESTHESIA DURING PLEURAL PUNCTURE | 0 | ||||||||||
125029213 | 12502921 | 13 | C | SILYMARIN | MILK THISTLE | 1 | Unknown | 0 | |||||||||||
125029213 | 12502921 | 14 | C | SILYMARIN | MILK THISTLE | 1 | 0 | ||||||||||||
125029213 | 12502921 | 15 | C | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | Unknown | 0 | |||||||||||
125029213 | 12502921 | 16 | C | ONDANSETRON | ONDANSETRON | 1 | Unknown | 0 | |||||||||||
125029213 | 12502921 | 17 | C | ONDANSETRON | ONDANSETRON | 1 | Unknown | 0 | |||||||||||
125029213 | 12502921 | 18 | C | ONDANSETRON | ONDANSETRON | 1 | 0 | ||||||||||||
125029213 | 12502921 | 19 | C | RANITIDINE. | RANITIDINE | 1 | Unknown | 0 | |||||||||||
125029213 | 12502921 | 20 | C | RANITIDINE. | RANITIDINE | 1 | Unknown | 0 | |||||||||||
125029213 | 12502921 | 21 | C | RANITIDINE. | RANITIDINE | 1 | 0 | ||||||||||||
125029213 | 12502921 | 22 | C | ASCORBIC ACID. | ASCORBIC ACID | 1 | Unknown | INDICATION: PREVENTION OF ELECTROLYTE IMBALANCE DURING DIURETIC THERAPY | 0 | ||||||||||
125029213 | 12502921 | 23 | C | MAGNESIUM ASPARTATE/POTASSIUM ASPARTATE | 2 | Unknown | INDICATION: PREVENTION OF ELECTROLYTE IMBALANCE DURING DIURETIC THERAPY | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125029213 | 12502921 | 1 | Non-small cell lung cancer |
125029213 | 12502921 | 2 | Non-small cell lung cancer |
125029213 | 12502921 | 3 | Non-small cell lung cancer |
125029213 | 12502921 | 4 | Chest pain |
125029213 | 12502921 | 5 | Back pain |
125029213 | 12502921 | 6 | Chest pain |
125029213 | 12502921 | 7 | Back pain |
125029213 | 12502921 | 8 | Chest pain |
125029213 | 12502921 | 9 | Back pain |
125029213 | 12502921 | 10 | Aspartate aminotransferase increased |
125029213 | 12502921 | 11 | Blood lactate dehydrogenase increased |
125029213 | 12502921 | 12 | Anaesthesia |
125029213 | 12502921 | 13 | Aspartate aminotransferase increased |
125029213 | 12502921 | 14 | Blood lactate dehydrogenase increased |
125029213 | 12502921 | 15 | Premedication |
125029213 | 12502921 | 16 | Premedication |
125029213 | 12502921 | 17 | Nausea |
125029213 | 12502921 | 18 | Vomiting |
125029213 | 12502921 | 19 | Premedication |
125029213 | 12502921 | 20 | Nausea |
125029213 | 12502921 | 21 | Vomiting |
125029213 | 12502921 | 22 | Prophylaxis |
125029213 | 12502921 | 23 | Prophylaxis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125029213 | 12502921 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125029213 | 12502921 | Hallucination | |
125029213 | 12502921 | Hypotension | |
125029213 | 12502921 | Nausea | |
125029213 | 12502921 | Pulmonary oedema | |
125029213 | 12502921 | Urinary retention | |
125029213 | 12502921 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125029213 | 12502921 | 1 | 20151008 | 0 | ||
125029213 | 12502921 | 2 | 20151008 | 0 | ||
125029213 | 12502921 | 3 | 20151008 | 0 | ||
125029213 | 12502921 | 4 | 201507 | 0 | ||
125029213 | 12502921 | 6 | 20150920 | 20151013 | 0 | |
125029213 | 12502921 | 8 | 20150920 | 20151201 | 0 | |
125029213 | 12502921 | 10 | 20150930 | 20151002 | 0 | |
125029213 | 12502921 | 12 | 20151006 | 20151006 | 0 | |
125029213 | 12502921 | 13 | 20151008 | 20151210 | 0 | |
125029213 | 12502921 | 15 | 20151008 | 20160217 | 0 | |
125029213 | 12502921 | 16 | 20151008 | 20160217 | 0 | |
125029213 | 12502921 | 17 | 20151009 | 20151009 | 0 | |
125029213 | 12502921 | 19 | 20151008 | 20160217 | 0 | |
125029213 | 12502921 | 20 | 20151009 | 20151009 | 0 | |
125029213 | 12502921 | 22 | 20151009 | 20151009 | 0 | |
125029213 | 12502921 | 23 | 20151009 | 20151009 | 0 |